Business
AstraZeneca COVID-19 vaccine faces regulatory hurdles as Novavax releases both ‘encouraging’ and ‘concerning’ results – ABC News
European regulatory bodies are questioning the lack of data supplied for the Oxford-AstraZeneca vaccine, recommending against its use for the elderly, as another…
Experts say the problems associated with “first-generation” COVID-19 vaccines are being exposed, as one European regulatory body questions the lack of data supplied for the Oxford-AstraZeneca vaccine and recommends against its use for the elderly.
Key points:
- European regulatory bodies are concerned over the lack of data for the elderly during trials of the Oxford-AstraZeneca vaccine
- The TGA, described as “the best regulator in the world” by the Health Minister, is expected to make a decision in…
Continue Reading
-
General23 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News23 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General12 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
General19 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m